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To the Editor: As members of the French Ministry 
of Health Working Group on autochthonous urinary schis-
tosomiasis, we read with interest the 2 recently published 
articles regarding schistosomiasis screening of travelers to 
Corsica, France (1,2). Surprisingly, the authors of both ar-
ticles lacked evidence to support the diagnosis of schistoso-
miasis in most of what they referred to as confirmed cases. 
The diagnostic standard for confirmation of urinary schis-
tosomiasis is identification of eggs by microscopic exami-
nation of urine samples (3–5). If this criterion were applied 
in both reports, only 1 patient of the 7 allegedly confirmed 
cases would actually be confirmed.
The low sensitivity of microscopy is well known. 
Therefore, different serologic tests have been developed, 
including Western blot (WB). In the study based on travel-
ers from Italy (1), the SCHISTO II WB IgG test (LDBIO 
Diagnostics, Lyon, France) was used. This test, available 
since 2015, is based on both Schistosoma haematobium and 
S. mansoni antigens and has not been evaluated by anyone 
other than the manufacturer. Moreover, the authors did not 
report any details regarding the molecular weight and num-
ber of specific bands observed on the strip.
In the study by authors from the GeoSentinel Surveil-
lance Network (2), both cases that could have been infected 
after 2013, since exposure occurred only in 2014, and 4 
cases which reported bathing in rivers in Corsica other than 
the Cavu River had just 1 weakly positive serologic screen-
ing test. Hence, irrespective of the criteria for a confirmed 
case of schistosomiasis described above, it appears difficult 
to conclude that confirmation could rely on only 1 positive 
serologic test, even a WB.
Altogether, these 2 studies identified only 1 patient with 
parasitological evidence of infection that was attributable to 
the already known 2013 focus in Cavu River. Therefore, these 
articles do not provide evidence of transmission of schistoso-
miasis in Corsica after 2013 or outside the Cavu River.
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In Response: Regarding the comments by Berry et al. 
(1) on our previously published letter, we acknowledge that, 
in strict parasitological terms, confirmation of the diagno-
sis of urogenital schistosomiasis requires the identification 
of eggs by microscopic examination of urine. Neverthe-
less, we aimed at an operational case definition, providing 
criteria for identifying cases most likely to be true infec-
tions. We should not forget that microscopy has an unac-
ceptably low sensitivity (2). We should also consider that 
currently available serologic tools are hampered by both 
a poor sensitivity and a poor specificity for Schistosoma 
haematobium (3). Regarding immunoblot, Berry et al. are 
correct in saying that there is not yet any formally pub-
lished evidence of its accuracy for S. haematobium and that 
the high specificity declared, close to 100%, is based on 
data provided by the manufacturer. A formal study on the 
accuracy of this test is underway at the Centre for Tropical 
Diseases of Sacro Cuore Hospital. This assay has been less 
extensively assessed than that in which purified S. mansoni 
antigen is used, as described previously, which has shown 
very high accuracy (4). However, Western blot is already 
accepted as a diagnostic standard for the identification of 
other infectious diseases, including parasitic infections 
such as cysticercosis (for which, indeed, the direct parasito-
logical confirmation is often impossible), and has become 
the test of choice for the latter (5). 
Moreover, the population in our study was composed 
of persons not exposed to other parasites. Therefore, cross-
reactions with other helminths would be extremely unlikely.
In conclusion, although we recognize that, by a strictly 
semantic definition, the term “confirmed” should be re-
served for cases for which there is a parasitological proof, 
in operational terms, we could not rely on a direct test that 
has such a poor sensitivity in this particular patient popu-
lation. Had we done so, we would have found a subesti-
mated, and therefore totally incorrect, picture of the true 
prevalence, leading to inappropriate conclusions and ac-
tions (or lack thereof).
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In Response: We agree with Berry et al. (1) that the 
diagnostic standard for confirmation of urinary schis-
tosomiasis is the identification of eggs by microscopic 
examination of urine, especially in patients living in 
endemic areas with high schistosome loads. However, 
this approach may not apply to travelers who have low 
parasite loads and in whom the diagnosis relies mainly 
on serologic testing (2,3). Given the very poor sensitiv-
ity of egg detection in non–schistosomiasis-endemic set-
tings, most tropical and travel medicine clinics in Europe 
use conventional microscopy systematically combined 
with 2 different (commercial or in-house) serologic tests 
(2). The sensitivity of this approach (i.e., diagnosis of 
infection if combined ELISA and hemagglutination in-
hibition assay or an indirect fluorescent antibody test are 
positive) is >78% for chronic urinary schistosomiasis; 
specificity is 75%–98% when using various in-house 
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